This inventor holds 1 USPTO granted patent. Top assignee: Sanofi. Active years: 1989.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1989
Title: The Innovations of Jean-Claude Verniere
Introduction
Jean-Claude Verniere is a notable inventor based in Muret, France. He has made significant contributions to the field of chemistry, particularly through his innovative work on quinolone carboxamides. His dedication to research and development has led to the creation of valuable patents that enhance our understanding of chemical compounds.
Latest Patents
One of Jean-Claude Verniere's key patents is focused on N-alkoxyalkyl derivatives of quinolone carboxamides. This invention concerns new derivatives of 4-oxo-1,4-dihydro-quinoline 3-carboxamide, which adhere to a specific general formula. The patent highlights the versatility of the compounds, where R₁ can represent a linear or branched lower alkyl radical, an alkenyl or alkynyl radical, or a cycloalkyl radical, showcasing the potential applications of these derivatives in various fields.
Career Highlights
Jean-Claude Verniere has been associated with Sanofi, a leading global healthcare company. His work at Sanofi has allowed him to contribute to the development of innovative pharmaceutical solutions. With a patent portfolio that includes 1 patent, Verniere has established himself as a key figure in the realm of chemical inventions.
Collaborations
Throughout his career, Jean-Claude Verniere has collaborated with esteemed colleagues such as Jacques Simiand and Peter E Keane. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and advancements in research.
Conclusion
Jean-Claude Verniere's contributions to the field of chemistry through his innovative patents and collaborations highlight his importance as an inventor. His work continues to influence the development of new chemical compounds, paving the way for future advancements in the industry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
